郭大伟

Professor Supervisor of Doctorate Candidates

Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways

Release time:2024-12-26Hits:

Impact Factor:

3.9
Affiliation of Author(s):

动物医学院
Journal:

BREAST CANCER RESEARCH AND TREATMENT
Co-author:

Fang Tian,Hu Shiheng,Song Xinhao,Wang Junqi,Zuo Runan,Yun Shifeng,Jiang Shanxiang,Guo Dawei
Document Code:

2c9e868c936bae8501938a42f7634ba8
Volume:

207
Issue:

2
Page Number:

435-451
Translation or Not:

no
Date of Publication:

2024-09-01